CSIRO’s health-related research utilises sets of skills from across the organisation to develop new products, strategies and technologies. A better understanding of emerging diseases and conditions will help in their prevention, detection and management.
CSIRO scientists have developed a new system to screen for compounds that can inhibit one of the processes that takes place during the progression of Alzheimer’s disease.
The Australian Alzheimer’s disease cluster study – The Australian Imaging, Biomarker and Lifestyle Flagship Study of Ageing (AIBL) – has secured its first collaborative research agreement with a major strategic alliance partner, Pfizer Australia.
CSIRO is working to develop the most sensitive, accurate and timely diagnostic tests. These are critical to any eradication campaign in the event of an animal disease outbreak.
CSIRO’s large, integrated team of professional scientists and engineers research the new physics of the nanoscale. They cover biomimetics, nanoparticle films, biosensor arrays and molecular electronics.
In this video extract from the television program Catalyst, CSIRO's Dr Michael Fenech says that damage to the genome is a fundamental disease that can be diagnosed and treated. (8:00)
A video showing an interview of the Kolling Institute's Kerrie MacDonald, as she speaks about how the Kolling Institute and CSIRO have discovered genes that differentiate between different types of brain tumours. (0:49)
Dr Caroline Kerr is a research scientist with extensive experience studying the link between genes and stress in livestock animals. She is currently working on a project to develop tools to detect colorectal cancer in humans.
The nanobiotechnology program led by Dr Ted McMurchie has the potential to develop new biosensors to diagnose human diseases and disorders. Such biosensors mimic the processes carried out by cell membrane proteins.
The improvements in diagnostics and biomarkers with hyperspectral imaging are described in this document. It describes CSIRO hyperspectral imaging solutions for fast and reliable means of characterising the biochemistry in tissue, either to diagnose disease or to identify specific metabolic processes. (2 pages)
